Alan Bye

3.2k total citations
89 papers, 2.6k citations indexed

About

Alan Bye is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, Alan Bye has authored 89 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in Alan Bye's work include Analytical Methods in Pharmaceuticals (13 papers), HIV/AIDS drug development and treatment (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Alan Bye is often cited by papers focused on Analytical Methods in Pharmaceuticals (13 papers), HIV/AIDS drug development and treatment (10 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Alan Bye collaborates with scholars based in United Kingdom, United States and Italy. Alan Bye's co-authors include Lindsey Cass, Constantin Efthymiopoulos, Alison E. Mackie, L.F. Lacey, Oliver N. Keene, G. Land, Katy H. P. Moore, Mark Johnson, Gary E. Pakes and Geoffrey J. Yuen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

Alan Bye

88 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Bye United Kingdom 30 608 453 390 368 363 89 2.6k
William G. Kramer United States 31 349 0.6× 255 0.6× 377 1.0× 739 2.0× 381 1.0× 117 2.9k
Richard N. Upton Australia 36 388 0.6× 405 0.9× 415 1.1× 543 1.5× 242 0.7× 190 5.3k
John C. Somberg United States 28 363 0.6× 233 0.5× 327 0.8× 843 2.3× 149 0.4× 203 4.2k
Christine Lehmann Canada 34 843 1.4× 410 0.9× 485 1.2× 759 2.1× 331 0.9× 343 4.7k
Francesco Scaglione Italy 39 648 1.1× 241 0.5× 446 1.1× 991 2.7× 438 1.2× 195 4.5k
Jeffrey L. Barnett United States 34 262 0.4× 431 1.0× 709 1.8× 339 0.9× 146 0.4× 71 4.1k
Robert A. Blum United States 24 281 0.5× 162 0.4× 107 0.3× 296 0.8× 396 1.1× 83 2.4k
Lars Ståhle Sweden 33 593 1.0× 277 0.6× 79 0.2× 927 2.5× 440 1.2× 68 3.6k
Marijn M. Speeckaert Belgium 36 541 0.9× 494 1.1× 305 0.8× 970 2.6× 326 0.9× 195 4.6k
Tomohiro Nakayama Japan 30 488 0.8× 406 0.9× 305 0.8× 958 2.6× 146 0.4× 223 3.6k

Countries citing papers authored by Alan Bye

Since Specialization
Citations

This map shows the geographic impact of Alan Bye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Bye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Bye more than expected).

Fields of papers citing papers by Alan Bye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Bye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Bye. The network helps show where Alan Bye may publish in the future.

Co-authorship network of co-authors of Alan Bye

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Bye. A scholar is included among the top collaborators of Alan Bye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Bye. Alan Bye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trist, David G., Adam F. Cohen, & Alan Bye. (2013). Clinical pharmacology in neuroscience drug discovery: quo vadis?. Current Opinion in Pharmacology. 14. 50–53. 3 indexed citations
2.
Bye, Alan. (2006). The strategic and tactical value of a 3D geotechnical model for mining optimization, Anglo Platinum, Sandsloot open pit. Queensland's institutional digital repository (The University of Queensland). 106(2). 97–104. 7 indexed citations
3.
Bye, Alan. (2006). The application of multi-parametric block models to the mining process. Queensland's institutional digital repository (The University of Queensland). 107(1). 259–266.
4.
Teneggi, Vincenzo, Stephen T. Tiffany, Lisa Squassante, et al.. (2005). Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. Psychopharmacology. 183(1). 1–12. 35 indexed citations
5.
Zamuner, Stefano, Roberto Goméni, & Alan Bye. (2002). Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approach. Nuclear Medicine and Biology. 29(1). 115–123. 20 indexed citations
6.
Goméni, Roberto, et al.. (2002). In Silico Prediction of Optimal in Vivo Delivery Properties Using Convolution-Based Model and Clinical Trial Simulation. Pharmaceutical Research. 19(1). 99–103. 10 indexed citations
7.
Goméni, Roberto, Vincenzo Teneggi, Laura Iavarone, Lisa Squassante, & Alan Bye. (2001). Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling.. Pharmaceutical Research. 18(4). 537–543. 16 indexed citations
8.
Goméni, Roberto, et al.. (2001). Computer-assisted drug development (CADD): an emerging technology for designing first-time-in-man and proof-of-concept studies from preclinical experiments. European Journal of Pharmaceutical Sciences. 13(3). 261–270. 25 indexed citations
9.
Mackie, Alison E., et al.. (2000). Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant. Clinical Pharmacokinetics. 39(Supplement 1). 17–22. 28 indexed citations
10.
Brindley, C., Christine Falcoz, Alison E. Mackie, & Alan Bye. (2000). Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler??, Diskus?? and Metered-Dose Inhaler in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 1–8. 25 indexed citations
11.
Falcoz, Christine, et al.. (2000). Bioavailability of Orally Administered Micronised Fluticasone Propionate. Clinical Pharmacokinetics. 39(Supplement 1). 9–15. 52 indexed citations
12.
Cass, Lindsey, Constantin Efthymiopoulos, & Alan Bye. (1999). Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers. Clinical Pharmacokinetics. 36(Supplement 1). 1–11. 162 indexed citations
13.
Cass, Lindsey, et al.. (1999). Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers. Clinical Pharmacokinetics. 36(Supplement 1). 21–31. 101 indexed citations
14.
Lacey, L.F., et al.. (1998). Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies. European Journal of Pharmaceutical Sciences. 6(4). 259–263. 14 indexed citations
15.
Drusano, George L., Brian M. Sadler, Judith Millard, et al.. (1997). Pharmacodynamics of 141W94 as determined by short term change in HIV RNA Influence of viral isolate baseline EC50. 37. 4. 4 indexed citations
16.
Rohatagi, Shashank, Alan Bye, Christine Falcoz, et al.. (1996). Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate. The Journal of Clinical Pharmacology. 36(10). 938–941. 46 indexed citations
17.
Reppas, Christos, L.F. Lacey, Oliver N. Keene, Panos Macheras, & Alan Bye. (1995). Evaluation of Different Metrics as Indirect Measures of Rate of Drug Absorption from Extended Release Dosage Forms at Steady-State. Pharmaceutical Research. 12(1). 103–107. 21 indexed citations
18.
Dring, L. G., et al.. (1992). The metabolism of 14C-tazadolene succinate in the dog. Xenobiotica. 22(8). 963–971. 1 indexed citations
19.
Mould, G. P., et al.. (1989). A comparison of the high-performance liquid chromatography and RIA measurement of medroxyprogesterone acetate. Journal of Pharmaceutical and Biomedical Analysis. 7(1). 119–122. 3 indexed citations
20.
Boulter, Etienne, Barry Thornton, D. J. Bauer, & Alan Bye. (1980). Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir.. BMJ. 280(6215). 681–683. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William G. Kramer Breakdown of academic impact, for papers by Richard N. Upton Breakdown of academic impact, for papers by John C. Somberg Breakdown of academic impact, for papers by Christine Lehmann Breakdown of academic impact, for papers by Francesco Scaglione Breakdown of academic impact, for papers by Jeffrey L. Barnett Breakdown of academic impact, for papers by Robert A. Blum Breakdown of academic impact, for papers by Lars Ståhle Breakdown of academic impact, for papers by Marijn M. Speeckaert Breakdown of academic impact, for papers by Tomohiro Nakayama
Rankless by CCL
2026